Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Immunol., 23 December 2025

Sec. Inflammation

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1748838

Correction: Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis

This article is a correction to:

  1. Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis

    1. Read original article
Jixin Li&#x;Jixin Li1†Yanan He&#x;Yanan He1†Yanjun QuYanjun Qu1Chengcheng RenChengcheng Ren1Xiaotong WangXiaotong Wang1Yan ChengYan Cheng1Liyuan SunLiyuan Sun1Xin ZhangXin Zhang2Guangmei Zhang*Guangmei Zhang1*
  • 1Department of Gynecology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China
  • 2Central Laboratory, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China

A Correction on
Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis

By Li J, He Y, Qu Y, Ren C, Wang X, Cheng Y, Sun L, Zhang X and Zhang G (2023) Front. Immunol. 14:1115504. doi: 10.3389/fimmu.2023.1115504

There was a mistake in Figure 3B as published. Two small images (a and b) were placed in the wrong position.

The corrected Figure 3B appears below. The positions of the two images have been swapped and updated.

Also, due to figure compression, the quality of the Western blot images for β-tubulin in Figure 2F and actin in Figure 6A was compromised. To avoid misleading readers, we have uploaded high-quality versions of these two WB images as requested.

Figure 2
Three black-and-white images show a bright, elongated object against varied backgrounds. The first and last images display the object on a white background, while the middle image features it in a darker context with blurred surroundings. The object appears consistent in each frame.

Figure 2. Identification of endometrial stromal cells and BST2 expression at the cellular level. (A, B), The identification of endometrial stromal cells on the morphology (A) and Immunofluorescence (B). (C, D), BST2 mRNA (C) and protein (D) expression at the cellular level. (E, F), Identification of the transfection efficiency of Si-BST2 at the mRNA (E) and protein (F) levels. *p < 0.05; **p < 0.01; ****p < 0.0001.

Figure 3
Fluorescence micrographs showing EdU, DAPI, and merged images. Top row: Si-NC treatment showing green EdU and blue DAPI fluorescence. Bottom row: Si-BST2 treatment with similar fluorescence patterns. Scale bars are included.

Figure 3. The effect of BST2 on cell proliferation and apoptosis. (A–C), The proliferation of EESCs was examined by CCK-8 assay (A) and EdU (B, C) after Si-BST2 or Si-NC treatment for 48 h. (D), The proliferation-related protein PCNA was measured by Western blot assay after Si-BST2 or Si-NC treatment for 48 h. (E), The Flow cytometry was performed to detect the apoptosis rates of the EESCs transfected with Si-BST2 or Si-NC. (F), Western blot analysis was used to measure the levels of Bax and Bcl2 in cells transfected with Si-BST2 or Si-NC. *p < 0.05; **p < 0.01.

Figure 6
Three panels display X-ray images. The left and right panels show bright areas on a light background with black bands. The center panel shows a similar bright area on a dark background with two bands.

Figure 6. BST2 activated the NF-κB signaling pathway. (A), The expressions of key proteins of NF-κB pathway were measured by western blot analysis after transfection with Si-BST2 or Si-NC for 48h. (B), The Representative images of Immunofluorescence showed the cellular localization of NF-κB p65 protein in EESCs after transfection with Si-BST2 or Si-NC for 48h. (C, D), The protein expressions of NF-κB pathway were measured by western blot analysis after treatment with Si-BST2 or Si-NC or/and the NF-κB pathway activator IL-1β. ns, p ≥ 0.05; *p < 0.05; **p < 0.01; ****p < 0.0001.

High-quality raw image of β-tubulin in Figure 2F:

High-quality raw image of actin in Figure 6A:

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: endometriosis, transcription factor, immune-related genes, NF‐κB, lymphangiogenesis, feedback loop

Citation: Li J, He Y, Qu Y, Ren C, Wang X, Cheng Y, Sun L, Zhang X and Zhang G (2025) Correction: Promotion of BST2 expression by the transcription factor IRF6 affects the progression of endometriosis. Front. Immunol. 16:1748838. doi: 10.3389/fimmu.2025.1748838

Received: 18 November 2025; Accepted: 27 November 2025; Revised: 18 November 2025;
Published: 23 December 2025.

Edited and reviewed by:

Bernd Rolauffs, University of Freiburg Medical Center, Germany

Copyright © 2025 Li, He, Qu, Ren, Wang, Cheng, Sun, Zhang and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Guangmei Zhang, aHlkeXlndWFuZ21laXpoYW5nQDEyNi5jb20=

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.